NCT03139240View on ClinicalTrials.gov

Opioid Analgesia for MAB

PHASE4CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
MABPain
Interventions
DRUG

Oxycodone 10mg oral

Oxycodone 10mg oral given for pain control in addition to standard of care medications in women undergoing medical abortion

OTHER

Placebo

Placebo given in addition to standard of care medications in women undergoing medical abortion

Trial Locations (1)

97005

Site 1, Beaverton

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

Oregon Health and Science University

OTHER

NCT03139240 - Opioid Analgesia for MAB | Biotech Hunter | Biotech Hunter